Mitochondrial dysfunction in COPD patients with low body mass index

European Respiratory Journal

Volumn 29, Issue 4, 2007, Pages 643-650

  Rabinovich, Roberto A ^a,f   Bastos, R ^a   Ardite, E ^a   Llinas L ^a   Orozco Levi, M ^b,c   Gea, J ^b,c   Vilaro J ^d   Barbera J A ^a   Rodriguez Roisin R ^a   Fernandez Checa J C ^e   Roca, J ^a  

^a Hospital Clinic   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITAT RAMON LLULL   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Endurance training; Glutathione; Mitochondrial respiration; Muscle dysfunction

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; GLUTATHIONE; GLUTATHIONE DISULFIDE; LACTIC ACID; UNCOUPLING PROTEIN 3;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; BODY COMPOSITION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXERCISE TEST; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LACTATE BLOOD LEVEL; LUNG FUNCTION TEST; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE EXERCISE; MUSCLE MASS; MUSCLE STRENGTH; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY CHAIN; TISSUE LEVEL; VASTUS LATERALIS MUSCLE;

AGED; BIOPSY; BODY COMPOSITION; BODY MASS INDEX; EXERCISE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; OXIDATION-REDUCTION; PHYSICAL ENDURANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RNA, MESSENGER;

EID: 34147131849     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00086306     Document Type: Article

References (47)

1. Global Initiative for Chronic Obstructive Lung Disease. www.goldcopd.com. Date created: 1997. Date last accessed: November, 2006.
2. Saey D, Debigare R, LeBlanc P, et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 425-430.
3. Skeletal muscle dysfunction in chronic obstructive pulmonary disease, A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159: S1-S40.
4. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21: 347-360.
5. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002; 121: Suppl. 5, 127S-130S.
6. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-1156.
7. Jones PW. Issues concerning health-related quality of life in COPD. Chest 1995; 107: Suppl. 5, 187S-193S.
8. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996; 154: 959-967.
9. Rabinovich RA, Ardite E, Troosters T, et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1114-1118.
10. Rabinovich RA, Ardite E, Mayer AM, et al. Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration 2006; 73: 757-761.
11. García-Ruiz C, Morales A, Ballesta A, Rodes J, Kaplowitz N, Fernández-Checa JC. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J Clin Invest 1994; 94: 193-201.
12. Gosker HR, Schrauwen P, Hesselink MK, et al. Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD. Eur Respir J 2003; 22: 88-93.
13. Russell AP, Somm E, Debigare R, et al. COPD results in a reduction in UCP3 long mRNA and UCP3 protein content in types I and IIa skeletal muscle fibers. J Cardiopulm Rehabil 2004; 24: 332-339.
14. Gosker HR, Schrauwen P, Broekhuizen R, et al. Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab 2006; 290: E976-E981.
15. Boss O, Samec S, Paoloni-Giacobino A, et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 1997; 408: 39-42.
16. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 442-447.
17. Bulteau AL, Szweda LI, Friguet B. Mitochondrial protein oxidation and degradation in response to oxidative stress and aging. Exp Gerontol 2006; 41: 653-657.
18. Gutiérrez J, Ballinger SW, Darley-Usmar VM, Landar A. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res 2006; 99: 924-932.
19. Orozco-Levi M. Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Eur Respir J 2003; 22: Suppl. 46, 41S-51S.
20. Jimenez-Fuentes MA, Gea J, Aguar MC, et al. [Capillary density and respiratory function in the external intercostal muscle]. Arch Bronconeumol 1999; 35: 471-476.
21. Ribera F, N'Guessan B, Zoll J, et al. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 873-879.
22. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
23. Schols AM, Wouters EF. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. Clin Chest Med 2000; 21: 753-762.
24. Roca J, Burgos F, Sunyer J, et al. References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J 1998; 11: 1354-1362.
25. Roca J, Burgos F, Barberà JA, et al. Prediction equations for plethysmographic lung volumes. Respir Med 1998; 92: 454-460.
26. Hards JM, Reid WD, Pardy RL, Pare PD. Respiratory muscle fiber morphometry. Correlation with pulmonary function and nutrition. Chest 1990; 97: 1037-1044.
27. Kotler DP, Burastero S, Wang J, Pierson RN Jr. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr 1996; 64: Suppl. 3, 489S-497S.
28. Dubowitz V, Brooke M, eds. Major Problems in Neurology. London, Saunders, 1973; pp. 74-85.
29. Research Services Branch (National Institutes of Health). Download Page (NIH Image, version 1.60). http://rsb.info.nih.gov/nih-image/ download.html. Date last accessed: May 2006.
30. Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology 1969; 19: 591-605.
31. Dunkley PR, Heath JW, Harrison SM, Jarvie PE, Glenfield PJ, Rostas JA. A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res 1988; 441: 59-71.
32. Colell A, García-Ruiz C, Lluis JM, Coll O, Mari M, Ferández-Checa JC. Cholesterol impairs the adenine nucleotide translocator-mediated mitochondrial permeability transition through altered membrane fluidity. J Biol Chem 2003; 278: 33928-33935.
33. Mahoney DJ, Carey K, Fu MH, et al. Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiol Genomics 2004; 18: 226-231.
34. Fariss MW, Reed DJ. High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives. Methods Enzymol 1987; 143: 101-109.
35. Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2807-2813.
36. Takabatake M, Nakamura H, Abe S, et al. The relationship between chronic hypoxaemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am Respir Crit Care Med 2000; 161: 1179-1184.
37. Pipinos II, Sharov VG, Shepard AD, et al. Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease. J Vasc Surg 2003; 38: 827-832.
38. Simon M, LeBlanc P, Jobin J, Desmeules M, Sullivan MJ, Maltais F. Limitation of lower limb V'02 during cycling exercise in COPD patients. Appl Physiol 2001; 90: 1013-1019.
39. Brunelle JK, Bell EL, Quesada NM, et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 2005; 1: 409-414.
40. Semenza GL, Agani F, Feldser D, et al. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 2000; 475: 123-130.
41. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3: 177-185.
42. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively down-regulating mitochondrial oxygen consumption. Cell Metab 2006; 3: 187-197.
43. Barreiro E, Gea J, Corominas JM, Hussain SN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003; 29: 771-778.
44. Coronell C, Orozco-Levi M, Ramírez-Sarmiento A, Martínez-Llorens J, Broquetas J, Gea J. [Low-weight syndrome associated with COPD in our setting]. Arch Bronconeumol 2002; 38: 580-584.
45. Coronell C, Orozco-Levi M, Gea J. COPD and body weight in a Mediterranean population. Clin Nutr 2002; 21: 437-438.
46. Schrauwen P, Hesselink MK. The role of uncoupling protein 3 in fatty acid metabolism: protection against lipotoxicity? Proc Nutr Soc 2004; 63: 287-292.
47. Schrauwen P, Hoeks J, Schaart G, et al. Uncoupling protein 3 as a mitochondrial fatty acid anion exporter. FASEB J 2003; 17: 2272-2274.